TSR-042 in People With Locally Advanced Mismatch Repair Deficient Rectal Cancer

Conditions:   Rectal Adenocarcinoma;   Clinical Stage: Stage II (T3-4, N-);   Stage III (Any T, N+) Interventions:   Drug: TSR-042;   Drug: capecitabine;   Radiation: Intensity Modulated Radiation Therapy (IMRT) Sponsors:   Memorial Sloan Kettering Cancer Center;   Tesaro, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials